Mersana Therapeutics, Inc. (MRSN)
NASDAQ: MRSN · Real-Time Price · USD
7.75
-0.36 (-4.44%)
At close: Aug 22, 2025, 4:00 PM
7.77
+0.02 (0.26%)
After-hours: Aug 22, 2025, 7:06 PM EDT

Mersana Therapeutics Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 20202016 - 2020
Period Ending
Jun '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2016 - 2020
34.7740.536.8626.580.040.83
Upgrade
Revenue Growth (YoY)
16.14%9.88%38.65%61716.28%-94.81%-98.03%
Upgrade
Cost of Revenue
71.6573.02148.27173.39132.0167.04
Upgrade
Gross Profit
-36.88-32.52-111.41-146.8-131.97-66.21
Upgrade
Selling, General & Admin
35.0940.8159.5456.9636.8921.9
Upgrade
Operating Expenses
35.0940.8159.5456.9636.8921.9
Upgrade
Operating Income
-71.97-73.34-170.96-203.77-168.86-88.11
Upgrade
Interest Expense
-3.34-3.87-4.07-3.33-1.27-0.36
Upgrade
Interest & Investment Income
5.638.4412.072.880.070.42
Upgrade
EBT Excluding Unusual Items
-69.68-68.77-162.96-204.21-170.06-88.05
Upgrade
Merger & Restructuring Charges
-3.94--8.71---
Upgrade
Pretax Income
-73.62-68.77-171.67-204.21-170.06-88.05
Upgrade
Income Tax Expense
0.420.42----
Upgrade
Net Income
-74.04-69.19-171.67-204.21-170.06-88.05
Upgrade
Net Income to Common
-74.04-69.19-171.67-204.21-170.06-88.05
Upgrade
Shares Outstanding (Basic)
555432
Upgrade
Shares Outstanding (Diluted)
555432
Upgrade
Shares Change (YoY)
2.12%5.54%23.98%32.69%14.79%41.37%
Upgrade
EPS (Basic)
-14.94-14.12-36.96-54.51-60.24-35.80
Upgrade
EPS (Diluted)
-14.94-14.12-36.96-54.51-60.24-35.80
Upgrade
Free Cash Flow
-79.76-82.47-171.05-51.56-140.64-75.17
Upgrade
Free Cash Flow Per Share
-16.10-16.83-36.83-13.76-49.81-30.56
Upgrade
Gross Margin
-106.07%-80.31%----
Upgrade
Operating Margin
-206.99%-181.09%-463.86%-766.59%-392693.02%-10641.30%
Upgrade
Profit Margin
-212.94%-170.86%-465.80%-768.26%-395488.37%-10633.45%
Upgrade
Free Cash Flow Margin
-229.39%-203.65%-464.12%-193.97%-327060.47%-9078.38%
Upgrade
EBITDA
-70.56-71.71-169.44-202.84-168-87.1
Upgrade
EBITDA Margin
-202.95%-177.07%----
Upgrade
D&A For EBITDA
1.411.631.520.930.861.01
Upgrade
EBIT
-71.97-73.34-170.96-203.77-168.86-88.11
Upgrade
EBIT Margin
-206.99%-181.09%----
Upgrade
Updated Aug 13, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q